Boston ScientificBSX -0.49%74 EV-to-FCF is 23.15 as of Jul. 10, 2026, which is 62% below its 10-year median of 61.27. GuruFocus rates BSX with a GF Score™ of 74/100 and a GF Value™ of $105.67 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 414 Medical Devices & Instruments companies, Boston Scientific ranks worse than 50.48% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Boston Scientific's Enterprise Value is $76,360 Mil.
Boston Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $3,298 Mil. Therefore, Boston Scientific's EV-to-FCF for today is 23.15.
The historical rank and industry rank for Boston Scientific's EV-to-FCF or its related term are showing as below:
BSX'
s EV-to-FCF Range Over the Past 10 Years
Min: -360.75 Med: 61.27 Max: 1364.82
Current: 23.15
During the past 13 years, the highest EV-to-FCF of Boston Scientific was 1364.82. The lowest was -360.75. And the median was 61.27.
BSX's EV-to-FCF is ranked worse than 50.48% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.19
vs BSX: 23.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Boston Scientific (NYSE:BSX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Boston Scientific's PE Ratio (TTM) for today is calculated as:
Boston Scientific's share price for today is $44.77.
Boston Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.390.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Boston Scientific EV-to-FCF Related Terms
Boston Scientific EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Boston Scientific's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boston Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Boston Scientific's EV-to-FCF falls into.
Boston Scientific's current Enterprise Value is $76,360 Mil.
Boston Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,298 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (BSX) has a EV-to-FCF of 23.15 as of Jul. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Boston Scientific and its competitors. This is 62% below median its historical median of 61.27. According to the industry distribution chart, Boston Scientific ranks #209 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Boston Scientific's EV-to-FCF too high?
Boston Scientific's current EV-to-FCF of 23.15 is 62% below median its 10-year median of 61.27. The Medical Devices & Instruments industry median EV-to-FCF is 23.19. Boston Scientific's value of 23.15 is 0.2% below this industry median. Based on the distribution chart, Boston Scientific ranks #209 out of 414 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Boston Scientific has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's EV-to-FCF compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #209 out of 414 companies for EV-to-FCF. This places Boston Scientific in the lower half of its industry. The industry median EV-to-FCF is 23.19. Boston Scientific's value of 23.15 is 0.2% below this benchmark. While the company's 10-year median is 61.27 vs. the industry median of 23.19, Boston Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boston Scientific's current EV-to-FCF of 23.15 is 0.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Boston Scientific and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boston Scientific's current EV-to-FCF is 23.15, which is 62% below median its own 10-year median of 61.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is $105.67, compared to a current price of $44.77 — trading 57.6% below its estimated fair value. The current EV-to-FCF is 23.15, which is 62% below median its 10-year median of 61.27 and 0.2% below the Medical Devices & Instruments industry median of 23.19. Boston Scientific's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Boston Scientific (BSX), the current EV-to-FCF is 23.15 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of $44.77 is trading 57.6% below its estimated GF Value™ of $105.67.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for BSX:
EV-to-FCF: 23.15 (62% below median its 10-year median of 61.27)
GF Value™: $105.67 vs. price of $44.77 (57.6% below fair value)
Industry Position: 0.2% below the Medical Devices & Instruments median (#209 of 414)
No single metric tells the full story. See the BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
74GF Score
Get the complete analysis for BSX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSX has been successfully added to your 
